Sponsor

CytomX Therapeutics

Clinical research sponsor

Published trials5

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

5 shown

Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast CancerNCT04596150 · lead sponsor · 2020-12-29

COMPLETED

PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid TumorsNCT03993379 · lead sponsor · 2019-11-20

TERMINATED

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLNCT03543813 · lead sponsor · 2018-06-15

COMPLETED

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsNCT03149549 · lead sponsor · 2017-06-01

TERMINATED

PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or LymphomasNCT03013491 · lead sponsor · 2017-01-19

TERMINATED

Sponsor roles

lead sponsor5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.